Berkshire Biomedical


Berkshire Biomedical

Tommy Rouse is a successful former banker and financial payments industry executive. He's an innovator, visionary, and builder, with a knack for assembling talented management teams. Susan Owen is a successful, dynamic brand creator, and marketing communications executive. Together they formed and personally funded Berkshire Biomedical.

In 2016, Tommy endured three consecutive spinal surgeries; the procedures and post-operative care went well, but the longer-term home recovery failed. His pain became unmanageable as he struggled to properly self-administer his medications and provide accurate adherence information to his doctor. Tommy was frustrated by his delayed recovery and became concerned as he learned of the increasing impacts on society of misuse and abuse of prescription drugs. Determined to find a better way, he called upon his long-time friend Susan, to brainstorm his idea for a solution.

The idea was to develop an easy to use, connected and data-driven medication delivery system to address the challenges and achieve their goal. They built a team of trusted and seasoned professionals and advisory board members with executive level backgrounds in healthcare, and extensive experience in early stage investing and product development in the med-tech and biotech industries. In addition, Berkshire has partnered with world class engineers, FDA regulatory advisors, and trademark and patent attorneys to support the business.

Berkshire has Reached its Development and FDA Submission Goals and is Ready for the Next Stage.

https://www.berkshirebiomedical.com/